What is Vera Therapeutics's common stock?

Vera Therapeutics (VERA) reported common stock of $72K in Q1 2026.

How has Vera Therapeutics's common stock changed year-over-year?

Vera Therapeutics's common stock increased by 12.5% year-over-year, from $64K to $72K.

What is the long-term trend for Vera Therapeutics's common stock?

Over 3 years (2022 to 2025), Vera Therapeutics's common stock has grown at a 36.4% compound annual growth rate (CAGR), from $28K to $71K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Vera Therapeutics VERA Common Stock

Common Stock at other companies

Travere Therapeutics, Inc.TVTX

$9K0.0%

Aurinia PharmaceuticalsAUPH

$1.09B-6.6%

Nektar TherapeuticsNKTR

390M+30.0%

Viridian Therapeutics, Inc.VRDN

200M0.0%

ImmunomeIMNM

$11K+22.2%

Iovance Biotherapeutics, Inc.IOVA

$18K+28.6%

Other financials

Income statement

See full

Operating income-$125.1M-119%

Net income-$121.0M-134%

EPS (diluted)-$1.69-109%

Balance sheet

See full

Cash & equivalents$114.4M+108%

Total debt$75.0M+37.8%

Total equity$499.7M-6.6%

Total assets$621.7M+1.9%

Cash flow

See full

Operating cash flow-$106.5M-95.8%

CapEx$23.0K-87.7%

Free cash flow-$106.5M-95.1%

Valuation

See full

Market cap$2.74B+87.5%

Enterprise value$2.7B+85.0%

Returns & leverage

See full

Return on equity-71.3%+296pp

Debt / equity0.2×0.0×

Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vera Therapeutics's common stock?: Vera Therapeutics (VERA) reported common stock of $72K in Q1 2026.
How has Vera Therapeutics's common stock changed year-over-year?: Vera Therapeutics's common stock increased by 12.5% year-over-year, from $64K to $72K.
What is the long-term trend for Vera Therapeutics's common stock?: Over 3 years (2022 to 2025), Vera Therapeutics's common stock has grown at a 36.4% compound annual growth rate (CAGR), from $28K to $71K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).